Patterns of B‐cell lymphocyte expression changes in pre‐ and post‐malignant prostate tissue are associated with prostate cancer progression

Patterns of B‐cell lymphocyte expression changes in pre‐ and post‐malignant prostate tissue are associated with prostate cancer progression

Abstract Backround Inflammation characterized by the presence of T and B cells is often observed in prostate cancer, but it is unclear how T‐ and B‐cell levels change during carcinogenesis and whether such changes influence disease progression. Methods The study used a retrospective sample of 73 pro...

Full description

Bibliographic Details
Main Authors:	Sudha M. Sadasivan, Ian M. Loveless, Yalei Chen, Nilesh S. Gupta, Ryan Sanii, Kevin R. Bobbitt, Dhananjay A. Chitale, Sean R. Williamson, Andrew G. Rundle, Benjamin A. Rybicki
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	Cancer Medicine
Subjects:	benign biopsy biochemical recurrence CD20 CD3 CD4 inflammation
Online Access:	https://doi.org/10.1002/cam4.7118

Similar Items

Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8+ T lymphocytes, NK‐cells, and high frequency of CD73+ stromal cells
by: Pélagie Mougola Bissiengou, et al.
Published: (2023-09-01)

Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: Relation to prognostic variables
by: Thanaa E. A. Helal, et al.
Published: (2013-01-01)

Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer
by: Stephen T. Ryan, et al.
Published: (2020-05-01)

Study of CD117 Expression and Its Relationship with Benign Prostatic Hyperplasia and Gleason Score in Prostatic Adenocarcinoma
by: Mehdi Rahmanpour, et al.
Published: (2023-11-01)

Racial differences in the systemic inflammatory response to prostate cancer.
by: Andrew G Rundle, et al.
Published: (2021-01-01)

Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
by: Yuan Meng, et al.
Published: (2021-06-01)

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
by: Yuan Meng, et al.
Published: (2021-10-01)

Primary Angiitis of the Central Nervous System in Adults: A Comprehensive Review of 76 Biopsy-Proven Case Reports
by: Lu P, et al.
Published: (2023-11-01)

Immunohistochemical Evaluation of CD3, CD4, CD8, and CD20 in Decidual and Trophoblastic Tissue Specimens of Patients with Recurrent Pregnancy Loss
by: Dimitrios Kavvadas, et al.
Published: (2022-02-01)

Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders
by: R Poongodi, et al.
Published: (2018-01-01)

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
by: Sean H. Lim, et al.
Published: (2018-11-01)

Immune cells and tryptophan metabolism in the joint capsule tissue in rheumatoid arthritis
by: E. A. Stepanov
Published: (2024-09-01)

Studying some lymphocyte subpopulations in search for predictors of renal graft dysfunction
by: S. V. Zybleva, et al.
Published: (2020-09-01)

Diagnostic significance of the determination of peripheral blood lymphocytes for predicting the onset of pregnancy in patients with repeated implant failures in groups with different protocols of the assisted reproductive technology program
by: T S Amyan, et al.
Published: (2017-10-01)

CD3+CD4+CD8+ T-LYMPHOCYTES COUNT IN PROGNOSIS OF EARLY KIDNEY ALLOGRAFT DYSFUNCTION
by: Zybleva S. V., et al.
Published: (2020-03-01)

Neolymphogenesis and Immunogistogochemical Study of Lymph Nodes in Breast Cancer
by: Sh. Kh. Gantsev, et al.
Published: (2020-01-01)

Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
by: Wattawan Wongpattaraworakul, et al.
Published: (2024-06-01)

Characterization of the Tumor Microenvironment and the Biological Processes with a Role in Prostatic Tumorigenesis
by: Cristina-Anita Ionescu, et al.
Published: (2022-07-01)

The origin of human CD20+ T cells: a stolen identity?
by: Marina Rode von Essen, et al.
Published: (2024-11-01)

Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
by: Stefan Gingele, et al.
Published: (2018-12-01)

Distribution of naive and memory/effector CD4+ T lymphocytes and expression of CD38 on CD8+ T lymphocytes in AIDS patients with tuberculosis
by: Rodrigues Denise do Socorro S., et al.
Published: (2003-01-01)

Distribution of naive and memory/effector CD4+ T lymphocytes and expression of CD38 on CD8+ T lymphocytes in AIDS patients with tuberculosis
by: Denise do Socorro S. Rodrigues, et al.

CD20+ B-LYMPHOCYTES, A HIGHLY INFORMATIVE BIOMARKER FOR EARLY DIAGNOSIS OF CHRONIC ENDOMETRITIS
by: Vera Nikolaevna Ellinidi, et al.
Published: (2019-03-01)

CD19: a promising target for systemic sclerosis
by: Kazuhiro Komura
Published: (2024-10-01)

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
by: Wei Sang, et al.
Published: (2020-08-01)

CD4 and CD20 as important immune markers in patients with pulmonary tuberculosis
by: Kamoona Firas Mohammad Hussein, et al.
Published: (2023-01-01)

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
by: Hongxia Wang, et al.
Published: (2021-08-01)

Primary cutaneous B‐Cell lymphoblastic lymphoma presenting with solitary scalp mass in a female child: A case report and review of the literature
by: Fatemeh Montazer, et al.
Published: (2022-11-01)

ANALYSIS OF PERIPHERAL BLOOD LYMPHOCYTES IN BURNS OF VARYING DEGREES IN THE ASSESSMENT OF IMMMUNE SUPPRESSION
by: Selma Arslanagic, et al.
Published: (2020-12-01)

Growth and differentiation factor 15 and NF‐κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection
by: Benjamin A. Rybicki, et al.
Published: (2021-05-01)

CD20<sup>+</sup>B LYMPHOCYTES, A HIGHLY INFORMATIVE BIOMARKER FOR EARLY DIAGNOSIS OF CHRONIC ENDOMETRITIS
by: V. N. Ellinidi, et al.
Published: (2019-07-01)

Evaluation PD-L1, CD8 and CD20 as early predictor and tracking markers for breast cancer (BC) in Egypt
by: Manar M. Hamed, et al.
Published: (2022-05-01)

Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets
by: Tiziana Vaisitti, et al.
Published: (2019-10-01)

The Immune Contexture in Canine Anal Sac Adenocarcinoma: Immunohistochemical Quantification of Tumor-Infiltrating Lymphocytes and Tumor-Associated Macrophages with Image Analysis
by: Barbara Bacci, et al.
Published: (2024-12-01)

Anticancer effects of a single intramuscular dose of a minicircle DNA vector expressing anti-CD3/CD20 in a xenograft mouse model
by: Xiaojuan Pang, et al.
Published: (2022-03-01)

Coexpresión de CD4 y CD8 en linfocitos de sangre periférica en pacientes positivos para VIH Peripheral blood lymphocyte CD4 and CD8 co-expression in HIV positive patients
by: Alberto Gómez, et al.
Published: (2008-12-01)

CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma
by: Dan Zhu, et al.
Published: (2024-12-01)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
by: Carla Fernanda Furtado Gardani, et al.
Published: (2023-11-01)

Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease
by: Natalia Druzhaeva, et al.
Published: (2021-09-01)

Genomic Variants Associated with Haematological Parameters and T Lymphocyte Subpopulations in a Large White and Min Pig Intercross Population
by: Naiqi Niu, et al.
Published: (2024-11-01)